Victory Capital Management Inc. Lowers Stock Position in Intuitive Surgical, Inc. $ISRG

Victory Capital Management Inc. cut its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 23.6% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 1,483,780 shares of the medical equipment provider’s stock after selling 457,530 shares during the quarter. Victory Capital Management Inc.’s holdings in Intuitive Surgical were worth $840,385,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently added to or reduced their stakes in ISRG. Holos Integrated Wealth LLC purchased a new stake in Intuitive Surgical during the fourth quarter worth $25,000. Newbridge Financial Services Group Inc. raised its position in Intuitive Surgical by 300.0% during the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 33 shares during the period. Olistico Wealth LLC acquired a new position in Intuitive Surgical during the fourth quarter worth $28,000. Caitlin John LLC acquired a new position in Intuitive Surgical during the third quarter worth $30,000. Finally, Laurel Wealth Advisors LLC acquired a new position in Intuitive Surgical during the fourth quarter worth $31,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Trading Down 0.4%

Intuitive Surgical stock opened at $411.06 on Friday. Intuitive Surgical, Inc. has a 12-month low of $396.68 and a 12-month high of $603.88. The stock has a market cap of $145.58 billion, a P/E ratio of 49.83, a PEG ratio of 3.30 and a beta of 1.46. The company has a 50-day moving average price of $442.88 and a 200 day moving average price of $496.19.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The firm had revenue of $2.77 billion during the quarter, compared to analysts’ expectations of $2.62 billion. During the same period last year, the business earned $1.81 earnings per share. Intuitive Surgical’s revenue was up 23.0% compared to the same quarter last year. As a group, analysts forecast that Intuitive Surgical, Inc. will post 8.57 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on ISRG. Wall Street Zen upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Saturday. BTIG Research restated a “buy” rating and set a $574.00 price objective on shares of Intuitive Surgical in a research report on Wednesday, April 22nd. Citigroup upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price objective for the company in a research report on Wednesday, March 11th. Barclays set a $651.00 price objective on shares of Intuitive Surgical and gave the stock an “overweight” rating in a research report on Thursday, April 23rd. Finally, Jefferies Financial Group reduced their price objective on shares of Intuitive Surgical from $560.00 to $515.00 and set a “hold” rating for the company in a research report on Wednesday, April 22nd. Nineteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $571.28.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Analyst coverage remains broadly constructive, with brokerage sentiment still at a “Moderate Buy” and recent EPS estimate increases signaling confidence in Intuitive Surgical’s growth outlook.
• Positive Sentiment: Recent commentary highlights that the company’s scale, cost discipline, and adoption of the da Vinci 5 platform could help protect margins even if tariffs and input costs remain a concern.
• Neutral Sentiment: Investor attention has increased around ISRG, which can support trading activity, but this appears more like watchlist interest than a fresh business catalyst.
• Neutral Sentiment: BofA trimmed its price target slightly to $515 from $520, which still implies upside but signals a bit less optimism than before. Article: BofA adjusts price target on Intuitive Surgical to $515 from $520
• Neutral Sentiment: Two executives sold shares under pre-arranged 10b5-1 plans, including EVP Gary Loeb and EVP Mark Brosius. The sales were relatively small and routine, so they are unlikely to be a major fundamental concern.
• Negative Sentiment: One recent research note was notably bearish, with Deutsche Bank cutting its target to $366 and maintaining a sell rating, reinforcing concerns that valuation may still be too rich despite the company’s strong operating performance.
• Negative Sentiment: Seeking Alpha published a view calling Intuitive Surgical an “excellent business, unattractive stock,” reflecting ongoing investor caution around the valuation. Article: Intuitive Surgical: Excellent Business, Unattractive Stock

Insider Buying and Selling

In other Intuitive Surgical news, EVP Gary Loeb sold 400 shares of the stock in a transaction dated Wednesday, June 10th. The shares were sold at an average price of $424.14, for a total transaction of $169,656.00. Following the completion of the transaction, the executive vice president owned 5,720 shares of the company’s stock, valued at $2,426,080.80. This trade represents a 6.54% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 119 shares of the stock in a transaction dated Wednesday, April 29th. The stock was sold at an average price of $463.50, for a total transaction of $55,156.50. Following the transaction, the director directly owned 120 shares of the company’s stock, valued at approximately $55,620. This trade represents a 49.79% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 7,169 shares of company stock worth $3,059,135. Insiders own 0.60% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.